Stockreport

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026 [Yahoo! Finance]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF competition and patent expirations in emerging markets threaten pricing power, while Novartis (NVS) holds 11.23% and Merck (MRK) holds 9.75% of the fund. Pfizer (PFE), B [Read more]